OBJECTIVES: To study the serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in children with autism spectrum disorder (ASD) and their association with the core symptoms of ASD. METHODS: A total of 150 ASD children aged 2-7 years (ASD group) and 165 healthy children matched for age and sex (control group) who were recruited at the outpatient service of Chongqing Health Center for Women and Children were enrolled as subjects. Autism Behavior Checklist (ABC) and Childhood Autism Rating Scale (CARS) were used to evaluate the core symptoms of the ASD children. Chemiluminescence was used to measure the serum levels of IGF-1 and IGFBP-3 in both groups. RESULTS: The ASD group had a significantly lower serum level of IGF-1 than the control group (P<0.05). The children with severe ASD had significantly lower serum levels of IGF-1 and IGFBP-3 than those with mild-to-moderate ASD (P<0.001). For the children aged 2-3 years, the ASD group had a significantly lower serum level of IGF-1 than the control group (P<0.05). Boys had a significantly lower serum level of IGF-1 than girls in both ASD and control groups (P<0.05). The serum levels of IGF-1 and IGFBP-3 were negatively correlated with the total score of CARS (r=-0.32 and -0.40 respectively, P<0.001). CONCLUSIONS: The reduction in serum IGF-1 level in early childhood may be associated with the development of ASD, and the serum levels of IGF-1 and IGFBP-3 are associated with the core symptoms of ASD children.
OBJECTIVES: To study the serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in children with autism spectrum disorder (ASD) and their association with the core symptoms of ASD. METHODS: A total of 150 ASD children aged 2-7 years (ASD group) and 165 healthy children matched for age and sex (control group) who were recruited at the outpatient service of Chongqing Health Center for Women and Children were enrolled as subjects. Autism Behavior Checklist (ABC) and Childhood Autism Rating Scale (CARS) were used to evaluate the core symptoms of the ASD children. Chemiluminescence was used to measure the serum levels of IGF-1 and IGFBP-3 in both groups. RESULTS: The ASD group had a significantly lower serum level of IGF-1 than the control group (P<0.05). The children with severe ASD had significantly lower serum levels of IGF-1 and IGFBP-3 than those with mild-to-moderate ASD (P<0.001). For the children aged 2-3 years, the ASD group had a significantly lower serum level of IGF-1 than the control group (P<0.05). Boys had a significantly lower serum level of IGF-1 than girls in both ASD and control groups (P<0.05). The serum levels of IGF-1 and IGFBP-3 were negatively correlated with the total score of CARS (r=-0.32 and -0.40 respectively, P<0.001). CONCLUSIONS: The reduction in serum IGF-1 level in early childhood may be associated with the development of ASD, and the serum levels of IGF-1 and IGFBP-3 are associated with the core symptoms of ASD children.
Authors: Claudia Schilling; Werner F Blum; Isabella Heuser; Georgios Paslakis; Stefan A Wudy; Michael Deuschle Journal: J Clin Psychopharmacol Date: 2011-06 Impact factor: 3.153
Authors: Sei Eun Hyun; Byung Churl Lee; Byung Kyu Suh; So Chung Chung; Cheol Woo Ko; Heung Sik Kim; Kee Hyoung Lee; Sei Won Yang; Choong Ho Shin; Jin Soon Hwang; Duk Hee Kim; Baek Keun Lim; Jong Duck Kim; Han-Wook Yoo; Hye Soon Kim; Woo Yeong Chung; Mi Jung Park; Young Jong Woo; Chan Jong Kim; Dae-Yeol Lee; Eun Young Kim; Jin Ho Choi; Heon Seok Han; Il Tae Hwang; Ho-Seong Kim Journal: Clin Biochem Date: 2011-10-12 Impact factor: 3.281
Authors: Seok-Jun Hong; Joshua T Vogelstein; Alessandro Gozzi; Boris C Bernhardt; B T Thomas Yeo; Michael P Milham; Adriana Di Martino Journal: Biol Psychiatry Date: 2020-04-22 Impact factor: 13.382
Authors: B Anlar; F Oktem; B Bakkaloglu; M Haliloglu; H Oguz; F Unal; B Pehlivanturk; B Gokler; C Ozbesler; N Yordam Journal: Neuropediatrics Date: 2007-06 Impact factor: 1.947